Jalota Deepika 4
4 · PMV Pharmaceuticals, Inc. · Filed Sep 13, 2022
Insider Transaction Report
Form 4
Jalota Deepika
Chief Development Officer
Transactions
- Award
Common Stock
2022-09-09+34,050→ 34,050 total
Footnotes (1)
- [F1]The reported shares are represented by restricted stock units, or RSUS. One- third of the RSUs vest on September 9, 2023 and the remaining shares vest on September 9, 2024.